Pathologies associated with impaired synthesis of heme group
PDF (Português (Brasil))

How to Cite

BUENO, . B.; SOARES, . S.; OLIVEIRA, . F. de. Pathologies associated with impaired synthesis of heme group. Revista Científica da FHO/Uniararas, Araras, SP, v. 2, n. 2, p. 70–79, 2014. DOI: 10.55660/revfho.v2i2.101. Disponível em: https://ojs.fho.edu.br:8481/revfho/article/view/101. Acesso em: 22 nov. 2024.

Abstract

The porphyrias are cutaneous or neurological diseases associated with inherited or acquired deficiencies which are characterized by partial deficiency in activity of the enzymes of the biosynthesis pathway of heme group, that leads to decreased levels in this group and to the accumulation of its metabolic precursors. The first step of heme biosynthesis occurs in mitochondria; the intermediate phases occur in the cytosol and final phases occur again in the mitochondria. There are several factors that participate in triggering of the disease such as drugs, alcohol, hormones, diet, stress, exposure to sunlight, among others. The classification of porphyrias is made according to the origin of the precursor in excess being Hepatic or Erythropoietic Porphyrias. These are also classified according to the clinical manifestations in Acute or Chronic, being neuropsychiatric symptoms, abdominal pain, vomiting, acute neuropathy, seizures and mental disturbances such as hallucinations, depression, paranoia and anxiety related to acute aspect. In chronic cases the clinical manifestation takes the form of cutaneous photosensitivity. The treatment is carried out after the detection of the symptoms. Porphyria is considered a rare disease with few studies related to it, this work covers its main characteristics differentiating it according to their classification.

https://doi.org/10.55660/revfho.v2i2.101
PDF (Português (Brasil))

References

ANDERSON, K. E. Recomendations for the diagnosis and treatment of the acute porphyrias. American College of Physicians, v. 142, n. 6, p.

- 451, 2005.

ANDERSON, K. E. Porfirias Distúrbios da Nutrição e do Metabolismo – Cap. 141 – Porfirias. Manual Merck, 2007.

BADMINTON, M. N.; ELDER, G. H. Molecular mechanisms of dominant expression in pophyria. Journal of Inherited Metabolic Disease, v. 28, n.3, p. 277-86, 2005.

BALWANI, M.; DESNIK, R. J. The porphyrias: advances in diagnosis and treatment. Departament of Genetics and Genomic Sciences. Mount Sinai School of Medicine, New York, 2012.

BLOOMER, J. R.; McGUIRE, B. M. Intermittent uneseplained abdominal pain: is it porphyria? Clin Gastroenterol Hepatol, v. 5, n. 11, p. 1255-8, 2007.

BONKOVSKY, H. L. Neurovisceral porphyrias: what a 15. hematologist needs to know. Hematol Am Soc Hematol Educ Program, p. 24-30, 2005.

DINARDO, C. L. et al. A. Porfirias: quadro clínico,diagnóstico e tratamento. Rev Med (São Paulo), v.89, n. 2, p. 106-14, 2010.

FRANK, E. L. Porphyrins and Porphyrias.University of Utah & Arup Laboratories Salt Lake City, Utah, 2010.

GONZÁLEZ, F. H. D; SILVA, S. C. Bioquímica clínica de proteínas e compostos nitrogenados – Bioquímica do grupo heme. In. Introdução à bioquímica clínica veterinária. 2. ed. Porto Alegre: Editora da Universidade Federal do Rio grande do Sul, 2006.

GRANADA, B. X. et al. The very first description of a patient with hepatoerythropoietic porphyria in Argentina. Biochemical and molecular studies. Cell Mol Biol (Noisy-le-gran), v. 55, n. 1, p. 61-5, 2009.

HANDSCHIN, C. et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell, v. 122, n. 4, p. 505-15, 2005.

HO, A. Y. et al. Precipitation of porphyria cutânea tarda by imatinib mesylate? British Journal of Haematology, v. 121, n. 2, p. 375, 2003.

HUSSAIN, S. M.; AHMED, S. I. Congenital Erythropoietic Porphyria- Gunther’s Disease Basis for Werewolves and Vampires. Journal of Rawalpindi Medical College (JRMC), v. 17, n. 2, p. 300-301, 2013.

LAU, K. C.; LAM, C. W. Automated imaging of circulating fluorocytes for the diagnosis of erythropoietic protoporphyria: a pilot study for population screening. Journal of Medical Screening, v. 15, n. 4, p. 199-203, 2008.

LONGO, D. L. et al. Manual de Medicina de Harrison. 18. ed. Porto Alegre: Artmed, 2013.

LOPES, D. A. et al. Porfiria aguda intermitente: relato de caso e revisão da literatura. Rev Bras Ter Intensiva, v. 20, n. 4, p. 429-34, 2008.

MAMONE, L. et al. Photodynamic inactivation of Gram-Positive bacteria employing natural resources. Journal of Photochemistry and Photobiology. B, Biology, p. 133:80-9, 2014.

MINDER, E. L. et al. A systematic review of treatment options for dermal photosensivity in erythropoietic protoporphyria. Cellualar and molecular biology (Noisy-Le- Grand, France),v. 55, n. 1, p. 84-97, 2009.

MURRAY, R. K. et al. Bioquímica ilustrada de Harper. 29. ed. Porto Alegre: Artmed, 2013.

NAOUM, P. C. Porfirias: classificação, fisiopatologia, genética e diagnóstico laboratorial. Academia de Ciência e Tecnologia de São José do Rio Preto, SP, Brasil. 2013.

NASCIMENTO, E. Da escravidão discursiva aos Orikis em sala de aula: Mito e música sacra de matriz africana na poética do Candombeiro. In: CONGRESSO INTERNACIONAL DA ABALIC, 11., 2008. Anais... São Paulo - Brasil, 2008.

NELSON, D. L.; COX, M. M. Princípios de Bioquímica. 4. ed. São Paulo: Sarvier, 2006.

PIERACH, C. A.; Porphyrias. In: BOPE, E. T.; KELLERMAN, R. D. Conn’s Current Therapy 2012. Philadelphia, PA: Saunders Elsevier, 2011.

PISCHIK, E. KAUPPINEN, R. Neurological manifestations of acute Intermittent porphyria. Cellular and Molecular biology (Noisy-le-Grand, France), v. 55, n. 1, p. 72-83, 2009.

POBLETE-GUTIÉRREZ, P. et al. The porphyrias: clinical presentation, diagnosis and treatment. European jornal of dermatology: EJD, v. 16, n. 3, p. 230-40, 2006.

SANTOS, A. B. O.; GOZZANI, T. S. A.; GROKE, D. F. Dor neuropática em pacientes com porfiria. Relato de Caso. Revista Brasileira de Anestesiologia, v. 60, n. 6, p. 636-638, 2010.

SANTOS, L. C. et al. Explicações médicas para o mito do vampirismo. Revista Médica de Minas Gerais, v. 23, n. 4, p. 526-531, 2013.

SASSA, S. Modern diagnosis and management of the porphyrias. British Journal of Haematology, v, 135, n. 3, p. 281-92, 2006a.

SASSA, S. The hematologic aspects of porphyria. In: LICHTMAN, M. A. et al. Williams hematology. New York: McGraw-Hill; 2006b.

SIEGESMUND, M. et al. The acute hepatic porphyrias: current status and future challenges. Best Practice & Research. Clinical Gastroenterology, v. 24, n. 5, p. 593-605, 2010.

SOONAWALLA, Z. F. et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet, v. 363, n. 9410, p. 705-6, 2004.

VOET, D.; VOET, J. G. Bioquímica. 3. ed. Porto Alegre: Artmed, 2006.

WOLFF, C.; FRANK, J.; POBLETEGUTIÉRREZ, P. Porfiria variegate en Chile: identificación de mutaciones en el genprotoporfirinógeno oxidase y su implicancia diagnóstica. Revista de Investigación Clínica, v. 58, n. 4, p. 289-295, 2006.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2014 Beatriz Baquião Bueno; Valéria Silva Soares; Célia Figueiredo de Oliveira

Downloads

Download data is not yet available.